Drug Type Small molecule drug |
Synonyms BVT-II |
Target |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), c-Kit inhibitors(Stem cell growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14N6 |
InChIKeyJLRIJKVMMZEKDF-UHFFFAOYSA-N |
CAS Registry1175017-90-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | GB | 01 Dec 2011 | |
Acute Myeloid Leukemia | Phase 2 | PL | 01 Dec 2011 | |
Acute Myeloid Leukemia | Phase 2 | CZ | 01 Dec 2011 | |
Acute Myeloid Leukemia | Phase 2 | SE | 01 Dec 2011 |